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Background: Malaria continues to be a major cause of infectious disease mortality in tropical regions.
However, deaths from malaria are most often not individually documented, and as a result overall
understanding of malaria epidemiology is inadequate. INDEPTH Network members maintain population
surveillance in Health and Demographic Surveillance System sites across Africa and Asia, in which individual
deaths are followed up with verbal autopsies.
Objective: To present patterns of malaria mortality determined by verbal autopsy from INDEPTH sites across
Africa and Asia, comparing these findings with other relevant information on malaria in the same regions.
Design: From a database covering 111,910 deaths over 12,204,043 person-years in 22 sites, in which verbal
autopsy data were handled according to the WHO 2012 standard and processed using the InterVA-4 model,
over 6,000 deaths were attributed to malaria. The overall period covered was 19922012, but two-thirds of the
observations related to 20062012. These deaths were analysed by site, time period, age group and sex to
investigate epidemiological differences in malaria mortality.
Results: Rates of malaria mortality varied by 1:10,000 across the sites, with generally low rates in Asia (one
site recording no malaria deaths over 0.5 million person-years) and some of the highest rates in West Africa
(Nouna, Burkina Faso: 2.47 per 1,000 person-years). Childhood malaria mortality rates were strongly
correlated with Malaria Atlas Project estimates of Plasmodium falciparum parasite rates for the same
locations. Adult malaria mortality rates, while lower than corresponding childhood rates, were strongly
correlated with childhood rates at the site level.
Conclusions: The wide variations observed in malaria mortality, which were nevertheless consistent with
various other estimates, suggest that population-based registration of deaths using verbal autopsy is a useful
approach to understanding the details of malaria epidemiology.
Keywords: malaria; Africa; Asia; mortality; INDEPTH Network; verbal autopsy; InterVA
Responsible Editors: Heiko Becher, University of Hamburg, Germany; Nawi Ng, Umea˚ University, Sweden.
*Correspondence to: Osman A. Sankoh, INDEPTH Network, PO Box KD213, Kanda, Accra, Ghana,
Email: osman.sankoh@indepth-network.org
A Corrigendum has been published for this paper. Please see http://www.globalhealthaction.net/index.php/
gha/article/view/27833
This paper is part of the Special Issue: INDEPTH Network Cause-Specific Mortality. More papers from
this issue can be found at http://www.globalhealthaction.net
Received: 3 July 2014; Revised: 6 September 2014; Accepted: 6 September 2014; Published: 29 October 2014
T
he epidemiology of malaria in Africa and Asia has
been extensively, but not always systematically,
investigated. Many studies have focused on young
children’s exposure to the disease (1), and to some extent
the effects on pregnant women (2), without evaluating
the malaria status of other population sub-groups. Few
studies have looked specifically at the impact of malaria
on older people (3). Many data have been taken from
heath facilities at various levels and may be influenced by
patterns of health services utilisation rather than clearly
representing malaria patterns within communities (4).
Some work has taken whatever data may be available
and sought to generalise patterns of malaria burden using
sophisticated modelling techniques (5). Nevertheless,
malaria remains as an important cause of infectious dis-
ease mortality in many parts of Africa, and some areas in
Asia and Latin America. WHO’s World Malaria Report
2013 suggests that malaria mortality rates fell by more
than 40% from 2000 to 2012, a period during which there
was substantial international investment in malaria con-
trol (6). However, although malaria transmission has
successfully been reduced in many former high-incidence
settings, few areas have become malaria-free. The need for
adequate, reliable evidence on malaria mortality in various
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populations therefore remains as important as ever, and data
at the population level are crucially needed to validate and
understand top-down estimates.
As is the case for deaths from all diseases, malaria deaths
are generally poorly verified and documented in Africa
and some parts of Asia. Attributing a death to malaria
after the event is not easy  in highly endemic areas, acute
febrile deaths may be likely to be described as malaria and
lead to over-attribution, whereas the converse may apply in
settings where malaria is uncommon. It has been suggested
that over-attribution of malaria as a clinical diagnosis in
endemic areas may even be dangerous (7). Because most
malaria deaths occur in areas not covered by routine death
certification, verbal autopsy (VA) methods have been used
in many settings as the only available source of cause of
death data, but their validity in absolute terms for assign-
ing malaria as a cause of death remains open to question.
Rapid diagnostic tests (RDTs) are becoming increasingly
widely used as a basis for malaria treatment decisions, and,
where RDT results are known from an illness leading to
death, either positive or negative RDTresults may increase
the available VA information and hence the accuracy of
cause of death attribution. Consequently in the WHO 2012
VA standard, specific items on a recent positive or negative
test result were introduced (8). However, it will be some
time before sufficient VAs are collected which include those
data items to assess their utility as part of the VA process.
In this paper, we present malaria-specific mortality
rates derived from standardised VA data in 22 INDEPTH
Network Health and Demographic Surveillance Sites
(HDSS) across Africa and Asia (9). Although these HDSSs
are not designed to form a representative network, each one
follows a geographically defined population longitudinally,
systematically recording all death events and undertaking
VAs on deaths that occur. Sites with longer time-series may
therefore be able to measure changes over time effectively.
Our aim is to present the malaria mortality patterns at each
site, comparing these community-level findings with other
information on malaria in Africa and Asia.
Methods
The overall public-domain INDEPTH dataset (10) from
which these malaria-specific analyses are drawn is described
in detail elsewhere (11), with full details of methods used,
which are also summarised here in Box 1. Briefly, the dataset
documents 111,910 deaths in 12,204,043 person-years of
observation across 22 sites, all processed in a standardised
manner. The Karonga site in Malawi did not contribute VAs
for children, and for that reason is excluded from further
analyses here. The InterVA-4 ‘high’ malaria setting was used
for all the West African sites, plus the East African sites
(with the exceptions, on the grounds of high altitude, of
Nairobi, Kenya and Kilite-Awlaelo, Ethiopia), on the basis
of local experience. All other sites used the ‘low’ setting; the
‘very low’ setting was not used. The InterVA-4 guideline is
that the ‘high’ setting is appropriate for an expected malaria
cause-specific mortality fraction (CSMF) higher than about
1%, though the setting chosen does not result in any great
dichotomisation of outputs; the clinical equivalent would be
a physician’s knowledge that his/her current case comes from
a setting where malaria is more or less likely, irrespective of
particular symptoms.
Kilite-Awlaelo, Ethiopia:
CSMF 2.11%
0.09/1,000 py
Nairobi, Kenya:
CSMF 1.07%
0.11/1,000 py
Kilifi, Kenya:
CSMF 2.87%
0.17/1,000 py
Kisumu, Kenya:
CSMF 11.61%
2.15/1,000 py
Ouagadougou,
Burkina Faso:
CSMF 9.46%
0.56/1,000 py
Taabo,
Côte d'Ivoire:
CSMF 12.61%
1.21/1,000 py  
Niakhar, Senegal:
CSMF 10.59%
0.86/1,000 py 
Farafenni,
The Gambia:
CSMF 8.63%
0.91/1,000 py 
Navrongo, Ghana:
CSMF 4.90%
0.48/1,000 py
Dodowa, Ghana:
CSMF 10.24%
0.78/1,000 py
Agincourt, South Africa:
CSMF 1.02%
0.09/1,000 py
Africa Centre, South Africa:
CSMF 0.40%
0.06/1,000 py
Nouna, Burkina Faso:
CSMF 25.53%
2.47/1,000 py
Ballabgarh, India:
CSMF 1.74%
0.13/1,000 py
Bandarban, Bangladesh:
CSMF 4.25%
0.24/1,000 py
Matlab, Bangladesh:
CSMF 0.005%
0.0003/1,000 py
AMK, Bangladesh:
none recorded
Chakaria, Bangladesh:
CSMF 0.25%
0.02/1,000 py
FilaBavi, Vietnam:
CSMF 0.37%
0.015/1,000 py
Purworejo, Indonesia:
CSMF 2.15%
0.13/1,000 py
Vadu, India:
CSMF 0.06%
0.003/1,000 py
Fig. 1. Map showing participating sites, with agesextime standardised cause-specific mortality fractions and mortality rates
for malaria.
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Box 1. Summary of methodology based on the detailed
description in the introductory paper (11)
Agesextime standardisation
To avoid effects of differences and changes in age
sex structures of populations, mortality fractions
and rates have been adjusted using the INDEPTH
2013 population standard (12). A weighting factor
was calculated for each site, age group, sex and
year category in relation to the standard for the
corresponding age group and sex, and incorpo-
rated into the overall dataset. This is referred to in
this paper as agesextime standardisation in the
contexts where it is used.
Cause of death assignment
The InterVA-4 (version 4.02) probabilistic model
was used for all the cause of death assignments in
the overall dataset (13). InterVA-4 is fully compli-
ant with the WHO 2012 Verbal Autopsy Standards
and generates causes of death categorised by
ICD-10 groups (14). The data reported here were
collected before the WHO 2012 VA standard was
available, but were transformed into the WHO
2012 and InterVA-4 format to optimise cross-site
standardisation in cause of death attribution. For a
small proportion of deaths VA interviews were
not successfully completed; a few others contained
inadequate information to arrive at a cause of
death. InterVA-4 assigns causes of death (max-
imum 3) with associated likelihoods; thus cases for
which likely causes did not total 100% were also
assigned a residual indeterminate component. This
served as a means of encapsulating uncertainty in
cause of death at the individual level within the
overall dataset, as well as accounting for 100% of
every death.
Overall dataset
The overall public-domain dataset (10) thus con-
tains between one and four records for each death,
with the sum of likelihoods for each individual
being unity. Each record includes a specific cause of
death, its likelihood and its age-sex-time weighting.
Deaths assigned to malaria were extracted from the
overall data set together with data on person-time exposed
by site, year, age and sex. Overall malaria mortality as re-
flected here amounted to a total of 6,330.8 agesextime
standardised deaths, to which 8,076 individually recorded
deaths contributed some component of probable malaria
mortality. As each HDSS covers a total population, rather
than a sample, uncertainty intervals are not shown.
In this context, all of these data are secondary datasets
derived from primary data collected separately by each
participating site. In all cases the primary data collection
was covered by site-level ethical approvals relating to on-
going health and demographic surveillance in those
specific locations. No individual identity or household
location data were included in the secondary data and no
specific ethical approvals were required for these pooled
analyses.
Results
The CSMFs for malaria at each site are shown, together
with the population-based malaria-specific mortality
rate per 1,000 person-years, in Fig. 1. In West African
sites, malaria CSMF ranged from 4.90% to 25.53%, with
malaria-specific standardised mortality rates ranging
from 0.48 to 2.47 per 1,000 person-years. In Eastern and
Southern Africa, CSMFs were 0.4011.61%, with rates
from 0.06 to 2.15 per 1,000 person-years. In Asia, CSMFs
were 04.25%, with rates from 0 to 0.24 per 1,000 person-
years. One site, AMK in Bangladesh, recorded no malaria
deaths in over 0.5 million person-years of observation.
Table 1 breaks down malaria-specific mortality rates by
age group and site. Malaria mortality rates among infants
varied considerably, from 0 to 1.4 per 1,000 person-years,
with the highest rates not necessarily being in the locations
with highest overall malaria mortality. The largest num-
bers of malaria deaths at most sites occurred in the 14
year age group, though the highest malaria mortality rate
in that age group was 0.43 per 1,000 person-years at Taabo,
Coˆte d’Ivoire. Malaria mortality rates in the 514 year age
group were generally lower than the rates for younger
children. Similarly, malaria mortality rates among adults
were generally lower than those for children, although they
tended to increase among the elderly. Figure 2 shows
malaria-specific mortality rates for each site by age group,
split into time periods (19921999; 20002005 and 2006
2012), depending on periods when individual sites operated.
Logarithmic scales have been used to visualise both high
and low levels of malaria mortality while using the same
scale for each site. For most sites and most periods there
were generally U-shaped relationships between malaria
mortality rates and age; naturally more random variation
was evident in sites with generally low malaria mortality
because of relatively small numbers of cases.
We undertook a sensitivity analysis to examine the
effects of the ‘high’ and ‘low’ InterVA-4 malaria settings
across this large and diverse dataset. Re-running the
InterVA-4 model with the ‘high’ and ‘low’settings reversed
at site level gave the results shown in Fig. 3. Incorrect use of
the ‘high’ setting in low malaria populations appeared to
result in high relative rates of falsely attributed malaria,
although the numbers involved would still be relatively
small at the lowest endemicities. Conversely using the ‘low’
setting in high malaria populations reduced the number of
malaria assignments. Although the rate ratios changed less
in high endemicity settings, the numbers of cases involved
would be important with increasing rates.
INDEPTH Network
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Table 1. Malaria-specific deaths and mortality rates per 1,000 person-years, by age group and site
Age group at death
Country: Site Infant 14 years 514 years 1549 years 5064 years 65 years
Bangladesh: Matlab
Deaths 0.00 0.41 0.00 0.00 0.00 0.00
Rate/1,000 py 0.00 0.00 0.00 0.00 0.00 0.00
Bangladesh: Bandarban
Deaths 0.98 1.00 2.46 3.76 1.47 3.25
Rate/1,000 py 0.79 0.17 0.18 0.11 0.25 1.03
Bangladesh: Chakaria
Deaths 0.43 1.23 1.99 0.00 0.00 0.28
Rate/1,000 py 0.08 0.06 0.03 0.00 0.00 0.03
Bangladesh: AMK
Deaths 0.00 0.00 0.00 0.00 0.00 0.00
Rate/1,000 py 0.00 0.00 0.00 0.00 0.00 0.00
Burkina Faso: Nouna
Deaths 507.76 859.38 140.73 108.93 76.24 287.96
Rate/1,000 py 0.75 0.20 0.11 0.07 0.42 0.70
Burkina Faso: Ouagadougou
Deaths 19.48 68.03 17.90 8.56 2.72 4.43
Rate/1,000 py 0.72 0.19 0.10 0.04 0.24 0.90
Coˆte d’Ivoire: Taabo
Deaths 22.74 63.22 8.24 22.79 2.99 8.56
Rate/1,000 py 1.42 0.43 0.14 0.11 0.43 1.35
Ethiopia: Kilite-Awlaelo
Deaths 1.83 2.22 1.22 1.00 0.70 4.93
Rate/1,000 py 0.57 0.13 0.03 0.02 0.06 0.41
The Gambia: Farafenni
Deaths 35.28 113.11 38.72 43.35 19.85 43.46
Rate/1,000 py 1.06 0.33 0.15 0.09 0.55 1.15
Ghana: Navrongo
Deaths 121.42 283.42 39.50 12.34 9.45 32.61
Rate/1,000 py 0.42 0.10 0.04 0.02 0.06 0.14
Ghana: Dodowa
Deaths 4.74 49.53 28.83 154.67 45.91 138.68
Rate/1,000 py 0.28 0.14 0.06 0.03 0.21 0.26
India: Ballabgarh
Deaths 5.41 17.89 3.64 4.25 0.00 5.38
Rate/1,000 py 0.45 0.20 0.04 0.02 0.00 0.26
India: Vadu
Deaths 0.00 0.00 0.00 0.91 0.00 0.00
Rate/1,000 py 0.00 0.00 0.00 0.01 0.00 0.00
Indonesia: Purworejo
Deaths 2.42 3.13 2.00 4.34 5.64 13.50
Rate/1,000 py 0.85 0.19 0.05 0.02 0.14 0.19
Kenya: Kilifi
Deaths 38.53 90.21 36.03 14.84 3.97 12.72
Rate/1,000 py 0.17 0.04 0.02 0.01 0.05 0.18
Kenya: Kisumu
Deaths 672.20 1177.46 177.79 321.30 99.16 181.89
Rate/1,000 py 0.38 0.10 0.04 0.03 0.14 0.17
Kenya: Nairobi
Deaths 16.42 16.50 4.59 7.23 3.91 0.26
Rate/1,000 py 0.80 0.18 0.04 0.02 0.15 0.05
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Table 2 shows estimates of malaria-specific mortality
rates for the countries with INDEPTH sites reporting
here, for the under-5 and 5-plus age groups for compar-
ison with other sources of malaria mortality estimates.
INDEPTH estimates for countries with multiple sites
were derived as population-weighted average rates.
The Malaria Atlas Project (MAP) produced geo-
referenced estimates of Plasmodium falciparum parasite
rates (PfPR) across endemic areas for children aged 210
years in 2010 (15). Since all the INDEPTH HDSSs cover
defined small areas, it was possible to extract a PfPR
value for each endemic site from the MAP data. Where
sites covered more than one cell of the MAP surface, all
the cells relating to the site were averaged. Data were
available for 14 sites with childhood malaria mortality
data; data were not available for seven sites in Vietnam,
India, Bangladesh and Ethiopia, presumably because of
very low or uncertain endemicity. Figure 4 shows the
Table 1 (Continued )
Age group at death
Country: Site Infant 14 years 514 years 1549 years 5064 years 65 years
Senegal: Niakhar
Deaths 23.25 126.45 21.32 16.31 4.04 28.49
Rate/1,000 py 1.05 0.33 0.15 0.09 0.22 0.68
South Africa: Africa Centre
Deaths 8.67 13.84 7.37 9.44 1.53 7.22
Rate/1,000 py 0.33 0.12 0.03 0.02 0.03 0.17
South Africa: Agincourt
Deaths 12.45 29.39 19.45 54.40 7.56 4.93
Rate/1,000 py 0.28 0.14 0.05 0.03 0.08 0.08
Vietnam: FilaBavi
Deaths 0.00 0.00 0.00 0.55 0.00 2.46
Rate/1,000 py 0.00 0.00 0.00 0.01 0.00 0.14
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Fig. 2. Malaria mortality rates by site, age group and period at 20 INDEPTH Network sites.
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correlation between per-site malaria mortality rates for
the 114 year age group as determined by InterVA-4 and
the MAP PfPR values for the same geographic locations.
The line in Fig. 4 represents a highly significant correla-
tion (R20.69, p0.002), fitting the relationship:
Malaria mortality rate ¼ e½ðPfPR0:6274Þþ0:7023
An important area of uncertainty in malaria epide-
miology is the ratio of malaria-specific mortality rates
between children and adults. Seventeen sites recorded
malaria deaths in both under-15 and over-15 year age
categories. Apart from one outlier (Dodowa, Ghana,
where the malaria-specific mortality rate ratio for over-15:
under-15 age categories was 2.5), in the remaining 16
sites the malaria-specific mortality rate ratios for over-
15:under-15 age categories were in the range 0.05 to 0.82,
while overall malaria-specific mortality rates ranged from
0.018 to 2.47 per 1,000 person-years. Figure 5 shows the
correlation between adult and child malaria rates for
these 17 sites, shown on logarithmic scales for clarity. As
expected, the sites from West Africa dominate the top-
right quadrant, together with Kisumu, on the shores of
Lake Victoria in Kenya. Other African and Asian sites
largely occupy the lower-left quadrant, with the Chakaria
site in Bangladesh showing very low malaria mortality
rates for both adults and children. The per-site correlation
(represented by the line in Fig. 5) between agesextime
standardised adult and child malaria mortality rates
was highly significant (R20.65, p0.0001), fitting the
relationship:
Adult malaria mortality rate
¼ e½ðchild malaria mortality rate1:002Þ1:157
Discussion
These results represent widely-based evidence on malaria
mortality, which has not previously been documented at
the population level on this scale, using standardised
methods. The interpretation of findings at individual sites
depends on local characteristics (1636). Two sites,
Ouagadougou in Burkina Faso and Nairobi in Kenya,
followed urban populations and recorded lower levels
of malaria than some of their rural neighbours. Bandarban
in Bangladesh is located in a frontier zone close to the
Myanmar border, which may explain higher rates of
malaria compared with other sites in Bangladesh; this is
consistent with WHO malaria mapping for Bangladesh
(37). The very low overall levels of malaria mortality in
Bangladesh are not only consistent with expectations, but
form an important part of these analyses in that they
suggest our methods are capable of assigning malaria as
a cause of death with high specificity. Kisumu in Kenya is
located on the shores of Lake Victoria, in an area known to
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Fig. 3. Sensitivity analysis showing the effect of choosing
the ‘wrong’ malaria endemicity setting (‘high’ and ‘low’
reversed) in processing VA data using the InterVA-4 model,
by site.
Table 2. Within-country estimates of malaria-specific mortality rates derived from WHO/CHERG (42, 43), IHME (44)
compared with population-weighted average country rates from INDEPTH sites
WHO/CHERG IHME INDEPTH
Country Under 5 years 5 years and over Under 5 years 5 years and over Under 5 years 5 years and over
Bangladesh 0.05 0.004 0.05 0.02 0.02 0.006
Burkina Faso 9.94 0.15 8.34 1.19 6.08 1.00
Coˆte d’Ivoire 6.92 0.13 5.49 0.92 5.04 0.57
Ethiopia 0.38 ? 1.86 0.36 0.32 0.06
Ghana 2.90 0.11 2.99 0.58 2.40 0.30
India 0.06 0.02 0.04 0.04 0.53 0.03
Indonesia 0.11 0.03 0.80 0.04 0.74 0.08
Kenya 0.47 ? 1.86 0.44 3.35 0.31
Senegal 2.39 0.05 1.96 0.59 2.95 0.39
The Gambia 4.31 0.14 5.55 0.46 2.34 0.61
Vietnam 0.004 0.000 0.003 0.013 0 0.015
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have higher malaria transmission than most other parts of
the country, such as the coastal area around Kilifi (38).
Kilite-Awlaelo is located in the Ethiopian highlands, at an
altitude around 2,000 m above sea level, at which malaria
is typically unstable and epidemic in nature. The two
South African sites are located on the margins of malaria
transmission, and some of the relatively few cases that
occurred may reflect travel, for example to neighbouring
Mozambique (39).
The validity of VA cause of death assignment specifi-
cally for malaria is difficult to determine precisely. The
InterVA model has previously been used in a WHO study
of malaria treatment, showing a significant difference in
malaria-specific mortality following a treatment delivery
intervention (40). A review of VA methodological valida-
tions in relation to hospital data found some examples
relating to malaria, but a generalisable formal validation
for malaria mortality remains elusive (41). In principle
validity of VA methods for malaria as a cause of death
could be established in a large VA dataset from an en-
demic area which included systematic parasitaemia test-
ing across all age groups. Operationally this could be
incorporated in a minimally-invasive autopsy approach
(42). The Population Health Metrics Research Consor-
tium (PHMRC) collected a ‘gold standard’ VA dataset
of 12,530 tertiary facility cases, which contained 216 cases
meeting the PHMRC definitions of a malaria death
(basically diagnoses based on parasitaemia and fever)
(43, 44). Unfortunately however there were no data on
the presence or absence of malaria parasitaemia in cases
attributed to other causes, nor on parasite species for
the malaria cases. Most (64%) of the adult malaria deaths
in this series came from hospitals in India, while the
childhood cases were mainly from Dar-es-Salaam city
(88%), though it should be noted that this study did not
aim to represent any particular population. Only 25% of
the malaria deaths mentioned the word ‘malaria’ in the
open-ended part of the subsequent VA interview (which
did not contain any specific question on malaria), while
69% of malaria case VAs for adults and 54% for children
reported severe respiratory symptoms. This may partly
reflect the tertiary facility settings of these cases, where
some cases may have progressed to respiratory complica-
tions of malaria (45), or VA respondents may simply
have noted hospital treatment for breathing difficulties
in the trajectory towards death (46). Consequently, the
PHMRC dataset is not particularly useful in terms of
validating VA in general for malaria.
The WHO 2012 VA standard (8) includes indicators
relating to positive or negative malaria test results during
the final illness, as well as other relevant symptomatic
parameters. However, because these data were collected
before the WHO 2012 standard was directly implemented
for data capture, specific responses for these indicators
were missing in over 90% of cases. However, a previous
sensitivity analysis showed that InterVA-4 was generally
relatively robust in relation to missing data items (46).
Nevertheless, the malaria-specific outputs here, using the
WHO 2012 standard and the corresponding InterVA-4
model, show huge differences between locations and age
groups, as might be expected. These plausible patterns
suggest that there may be at least a reasonable degree of
validity in terms of InterVA-4’s assignment of malaria
deaths. The application of a standard probabilistic model
such as InterVA-4 at least guarantees that inter-site
differences are reflections of variations in the VA source
data (13). If, alternatively, physicians at each site were used
to assign cause of death, it would be easy for inter- and
intra-physician variations to contribute to apparent differ-
ences between sites and over time. This is the first time
such a large VA dataset relating to malaria has been
compiled that spans complete populations in Africa and
Asia, covers a wide spectrum of endemicity, and uses
standardised cause of death attribution. The sensitivity
analysis reported here is important in justifying the design
assumptions in InterVA-4 that require local settings for
malaria (and HIV) endemicity. The crossover region
between the ‘high’ and ‘low’ settings, recommended at
1%, has been seen as a difficult concept by some InterVA-4
users. However, the sensitivity analysis shown in Fig. 3
suggests that this setting is both important and appro-
priate, and analogous to a clinician’s local knowledge
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Fig. 4. Scatter plot of agesextime standardised InterVA
malaria mortality rates per 1,000 person-years for children
aged 114 years versus Plasmodium falciparum parasite rate
data for children aged 210 years, for 14 INDEPTH HDSS
sites reporting malaria mortality which also had geo-
referenced parasite rate data for 2010 in the Malaria Atlas
Project (15). Line shows correlation, R20.56. (1. Africa
Centre, South Africa; 2. Agincourt, South Africa; 3. Nairobi,
Kenya; 4. Purworejo, Indonesia; 5. Bandarban, Bangladesh;
6. Kilifi, Kenya; 7. Dodowa, Ghana; 8. Navrongo, Ghana; 9.
Farafenni, The Gambia; 10. Ouagadougou, Burkina Faso;
11. Niakhar, Senegal; 12. Taabo, Coˆte d’Ivoire; 13. Kisumu,
Kenya; 14. Nouna, Burkina Faso).
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of malaria endemicity, irrespective of the history and
symptomatology of the next patient.
There are other major pieces of work describing ma-
laria mortality in Africa and Asia, using totally different
methods, with which these findings can be compared and
contrasted. The WHO World Malaria Report 2013 (6) sets
out WHO’s most recent compilation of malaria reports
from its member countries, together with associated data
estimates in the WHO Global Health Observatory (47)
and, for children, from the Child Epidemiology Reference
Group (CHERG) (48). The Institute of Health Metrics
and Evaluation (IHME) has also published global and
country estimates of malaria mortality covering a similar
time period, based on mathematical modelling of available
data (49). Both of these sources take the approach of
gathering whatever malaria mortality data may be avail-
able across all endemic areas (to which this dataset now
adds), and then making best estimates to fill in the con-
siderable gaps in the available data.
Table 2 enables comparisons of malaria-specific mor-
tality rates for the countries with INDEPTH sites re-
porting here, for the under-5 and 5-plus age groups, with
other sources of estimates. South Africa is not included
because the majority of the country is malaria-free, while
the two INDEPTH sites represent marginal transmission
areas, making national estimates difficult to interpret.
WHO and CHERG publish separate data estimates
for all-age malaria deaths and under-5 malaria deaths,
respectively; while these are largely congruent, allowing
the calculation of 5-plus deaths, for Kenya and Ethiopia
the number of under-5 deaths exceeded total deaths, so
that no rate could be calculated for the 5-plus age group.
Comparisons between these three data sources have to be
interpreted with care. The WHO/CHERG and IHME
numbers come from estimates based on such data as are
available, modelled to represent the national situation as
far as is possible, and may include facility and community
sources, as well as diverse methods of cause of death
assignment. The INDEPTH numbers come from the
specific HDSS populations as described above, which are
not intended to be nationally representative, but which
are collected and processed in a standardised way across
the various countries represented. In the case of Kenya,
for example, the higher INDEPTH rate for under-5s
reflects high malaria mortality in the Kisumu area. While
it would be inappropriate to over-interpret comparisons
of the rates presented in Table 2, it is clear that there are
substantial similarities between all three sources. IHME
and INDEPTH figures tend towards higher rates for the
5-plus age group, though the reasons for this are not
clear. In INDEPTH’s case, InterVA-4 appears to be
detecting a number of acute febrile illnesses among older
people and attributing them as malaria; but there is
absolutely no associated biomedical evidence that these
deaths are indeed directly due to malaria.
However, Fig. 4 showed a strong correlation between
InterVA-4 estimates of childhood malaria mortality and
geo-referenced parasite prevalence estimates from MAP
(15). There are three possible consequences to consider.
Firstly, if one accepts the validity of the parasite prevalence
estimates, then the observed correlation suggests that for
children (notwithstanding the slightly different age groups
of 114 years for mortality and 210 years for parasite
prevalence), InterVA-4 is capturing a directly related
pattern of malaria mortality, across a 100-fold range of
endemicity. The second option is to accept the validity of
the InterVA-4 malaria mortality findings reported here,
in which case they add veracity to the parasite prevalence
estimates. Thirdly, if both the InterVA-4 and MAP findings
are considered to be reasonably valid, then this correlation
establishes an interesting relationship between childhood
parasite prevalence and malaria mortality. This relation-
ship seems to hold over a wide range of sites, even though
it might be reasonable to presume that local factors such
as the effectiveness of treatment and control programmes
could also play a part. Previous work (among hospital-
ised cases) in Tanzania showed relationships between
age, transmission intensity and malaria mortality (50).
Another modelling study sought to establish relationships
between malaria transmission and mortality, though
starting from a rather disparate group of datasets (51).
Figure 5 showed a strong correlation between InterVA-4
adult and childhood malaria mortality rates at the site
level. If InterVA-4 were generally misclassifying a wide
range of acute adult febrile illnesses as malaria, this would
not be the expected pattern. If there were appreciable
misclassification, the so-called ‘malaria’ deaths in adults
might be expected to occur at a rate largely independent
of childhood malaria mortality, in the absence of any
hypothesis as to other causes of acute adult febrile
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mortality that happened to correlate geographically with
childhood malaria. However, there were clearly much
higher rates of what InterVA-4 was calling ‘malaria’
among adults in West Africa, where malaria transmission
is known to be the highest in the world. A more detailed
analysis of malaria mortality by age from the Kisumu site
in Kenya showed complex and changing relationships
between malaria mortality and age (52). Because malaria
surveillance among older people has generally not been
given high priority, there appears to be a need for further
population-based research to further resolve this question.
The public availability of these malaria mortality
data creates interesting opportunities for further analyses.
Apart from contributing to the overall body of malaria
mortality data, there are several other ways in which they
may be specifically useful. While one can debate the
generalisability of HDSS sites (53), the cross-site relation-
ships established here between gridded parasite preva-
lence data and childhood malaria mortality, and between
child and adult malaria mortality rates, could well be
incorporated into wider estimations of malaria mortality.
Conclusions
Measuring malaria mortality effectively continues to be a
global problem. As remarked in the context of malaria
transmission modelling (54), malaria mortality events
frequently fall under the radar of health information
systems. The data presented here, from a wide range of
INDEPTH HDSSs across Africa and Asia, demonstrate
the value of detailed longitudinal surveillance in defined
populations, rather than relying on more disparate
sources. VA may not be an ideal tool for tracking malaria,
but nevertheless the malaria-specific mortality rate esti-
mates obtained here using the WHO 2012 standard and the
InterVA-4 model closely correspond to other sources of
estimates, despite the 1:10,000 range in the magnitude of
rates measured using the same methods in different settings.
More widespread use of these population-based approaches
would add considerably to global understanding of malaria,
and thereby inform control and elimination programmes.
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